SARS-CoV-2 envelope protein mitochondrial localization reveals host metabolic disruption.
Level 5 - mechanism / opinion, no new human data
Bench research / in vitro laboratory study
PubMed 41933731 · doi:10.1016/j.jbc.2026.111419
What was done
Researchers investigated the intracellular localization and metabolic impact of the SARS-CoV-2 envelope (E) protein in host cells. Subcellular localization was assessed using fluorescence microscopy to examine colocalization with mitochondria and ceramide-rich domains. The authors performed lipidomic and metabolomic profiling, measured mitochondrial membrane potential, assessed reactive oxygen species (ROS) levels and apoptosis, and evaluated mitochondrial respiration using Seahorse mitochondrial stress testing.
What was found
SARS-CoV-2 E protein localized to host cell mitochondria in tubular cytoplasmic structures associated with ceramide-rich domains. Expression of E reduced cardiolipin, phosphatidylcholine, and lysophospholipids, decreased mitochondrial membrane potential, and impaired electron transport chain activity. Metabolomic analysis showed decreased glycolytic and tricarboxylic acid cycle intermediates alongside altered glutathione and sulfur metabolism, while glutamine levels increased. E protein expression elevated mitochondrial ROS without triggering host cell apoptosis. The abstract did not report specific numerical values or statistical effect sizes.
Why it matters
This study identifies a mechanism by which the SARS-CoV-2 E protein directly perturbs host mitochondrial function and lipid homeostasis, potentially promoting a metabolic shift toward aerobic glycolysis that supports viral replication without killing the host cell.
Limits
The study is limited to in vitro laboratory models, and the findings may not fully reflect responses during live viral infection in human tissues or in vivo systems. The abstract does not specify the host cell types utilized, sample sizes, replicate numbers, or quantitative effect sizes and statistical bounds.
Cited by
- supports SARS-CoV-2 enters the mitochondria and depletes cellular energy, driving long-term fatigue.